ArticleResuscitation plus2026
A comparison of the epidemiology and outcomes of true refractory and recurrent ventricular fibrillation out-of-hospital cardiac arrest: a retrospective study.
Article in Resuscitation plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To explore and compare patient characteristics and clinical outcomes across true-refractory and recurrent VF/pVT cases, at two commonly used time points, including after the first and third consecutive shocks. Methods: We performed a retrospective analysis of adult (≥16 years old) out-of-hospital cardiac arrest (OHCA) patients with initially shockable rhythms and complete defibrillator recordings between January 2019 and October 2022. Defibrillator recordings were reviewed using standardised criteria to classify patients into true-refractory VF/pVT, defined as persistent VF/pVT 5 s after shock delivery, and recurrent VF/pVT, defined as termination of arrhythmia at 5 s post-shock followed by recurrence at the end of the 2-minute CPR cycle. Multivariable logistic regression was used to examine the impact of true-refractory VF/pVT on survival outcomes and to identify factors associated with true-refractory VF/pVT. Results: Of the 2343 cases with complete defibrillator recordings, 1880 cases met the inclusion criteria. The incidence of true-refractory VF/pVT declined with increasing defibrillation attempts, accounting for 28.9%, 5.0%, and 1.0% of cases after the first, third and fifth consecutive shocks, respectively. Compared to patients with recurrent VF/pVT, true-refractory VF/pVT was associated with lower odds of survival to hospital discharge (adjusted odds ratio (AOR) 0.45, 95% CI: 0.22-0.92; Conclusion: Although associated with substantially worse outcomes, true-refractory VF/pVT is a time-limited condition, which typically responds to repeated defibrillation attempts. Further research is needed to determine whether earlier recognition and optimal management of true-refractory VF/pVT can improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.